CONTACT INFORMATIONBIOGRAPHYCREDENTIALSAWARDSPUBLICATIONSMatthew D. McGraw, M.D.Contact InformationPhone NumbersAdministrative: (585) 275-2464Fax: (585) 275-8706A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentAccepting New PatientsResearch LabsVisit Lab WebsiteLocationsGolisano Children's Hospital Pediatric Pulmonology601 Elmwood AveRochester, NY 14642-0001Pediatric Pulmonology: (585) 275-2464Faculty AppointmentsAssistant Professor - Department of Pediatrics , Pulmonology (SMD) Patient Care SettingPediatricsBiographyDr. McGraw's primary goal as a pediatric pulmonologist is to provide excellent care for all children and adolescents with underlying lung disease. He sees all patients with pediatric lung diseases including but not limited to cystic fibrosis, chronic lung disease of prematurity, and asthma. The primary focus of his basic science is better understanding the mechanisms of rare lung diseases, such as childhood interstitial lung disease (chILD) and bronchiolitis obliterans (BO), in order to identify new medical therapies.Professional BackgroundInherent of Dr. McGraw's practice is providing thoughtful, evidence-based, family-centered care to all children and families. His primary goal is to promote the greatest developmentally appropriate growth and potential of all children, consistent with the mission of the University of Rochester's Department of Pediatrics. He works collaboratively with parents, primary and other care providers to achieve the best outcomes for children and adolescents with underlying lung disease.ResearchDr. McGraw's research involves understanding the mechanisms of aberrant airway epithelial repair after inhalation injuries. The primary pediatric lung disease studied is bronchiolitis obliterans (BO), a devastating and often progressive fibrotic lung disease characterized by progressive luminal narrowing and obliteration of the small airways, or bronchioles. Despite BO's high morbidity and mortality, very little is known about its pathogenesis, and even less is available in terms of prevention, intervention and treatment. Inhalation agents used to study the mechanisms of aberrant airway epithelial repair include sulfur mustard (SM), a chemical warfare inhalation agent, and diacetyl, a volatile chemical in many flavorings. Both of these inhalation agents can cause bronchiolitis obliterans in children. Basic science techniques include: small animal model development; primary airway epithelial cell isolation; flow sorting; 3D cell culture; single cell RNA sequencing.CredentialsSpecialtiesPediatrics - American Board of PediatricsPediatric Pulmonology - American Board of PediatricsEducation2012MD | Suny Upstate Medical UniversityPost-doctoral Training & Residency07/01/2015 - 06/30/2018Fellowship in Pediatric Pulmonology at University of Colorado Hospital- GME07/01/2013 - 06/30/2015Residency in Pediatrics at University of Virginia Children's Hospital07/01/2012 - 06/30/2013Internship in Pediatrics at University of Virginia Children's HospitalVIEW ALL expand_moreAwards2020 - 2022KL2 AwardSponsor: NCATS and URMC CTSILocation: University of Rochester, Rochester, NY2020 - 2021Furth AwardSponsor: Office of the Provost, University of RochesterLocation: Rochester, NY2019 - 2021NIH Loan Repayment ProgramSponsor: NIEHSLocation: University of Rochester, Rochester, NY2018Best Research Poster, Junior FacultySponsor: Department of Pediatrics, Golisano's Children's HospitalLocation: Rochester, NY2017Society of Toxicology's Donald E. Gardner Inhalation Toxicology Education Award 20172016 - 2018NIH T32 Training Grant, University of Colorado SOM, 2016 –20182015Mulholland Resident and Fellow Teaching Award, Honorable Mention, 20152014 - 2015American Academy of Pediatrics, Resident CATCH Implementation Grant, 2014 – 20152014 - 2015University of Virginia Pediatrics Resident Teaching Award, 2014 & 20152011 - 2012Gold Humanism Honor Society2008Bucknell University Department of Biomedical Engineering, Magna Cum Laude2007 - 2008Tau Beta Pi Engineering Honor Society2005 - 2008Bucknell University Dean's ListVIEW ALL expand_morePublicationsJournal Articles2/28/2022McGraw MD, Croft DP, Nacca NE, Rahman I. "Reduced Plasma Phosphatidylethanolamines in E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI)." Pediatric pulmonology.. 2022 Feb 28; Epub 2022 Feb 28. 12/20/2021House EL, Kim SY, Johnston CJ, Groves AM, Hernady E, Misra RS, McGraw MD. "Diacetyl Vapor Inhalation Induces Mixed, Granulocytic Lung Inflammation with Increased CD4CD25 T Cells in the Rat." Toxics.. 2021 Dec 20; 9(12)Epub 2021 Dec 20. 11/9/2021Clair G, Bramer LM, Misra R, McGraw MD, Bhattacharya S, Kitzmiller JA, Feng S, Danna VG, Bandyopadhyay G, Bhotika H, Huyck HL, Deutsch GH, Mariani TJ, Carson J, Whitsett JA, Pryhuber GS, Adkins JN, Ansong C. "Proteomic Analysis of Human Lung Development." American journal of respiratory and critical care medicine.. 2021 Nov 9; Epub 2021 Nov 09. VIEW ALL PUBLICATIONSClose WindowSchedule an appointment with Matthew D. McGraw, M.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. Matthew D. McGraw, M.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.